Transpulmonary gradient and diastolic pressure gradient

In this study, elevated preoperative transpulmonary gradient was associated with significant increase in mortality at 6 months and 12 months after orthotopic heart transplantation. Elevated transpulmonary gradient is a risk factor for right heart failure after heart transplantation. Jahanyar J et al queried the UNOS (United Network for Organ Sharing) database from 1987 to 2017 and included adults who had complete transpulmonary gradient data. Those who underwent retransplant were excluded. Their sample consisted of 38,243 patients. It was found that median survival was higher in low transpulmonary gradient group (145 months vs 133 months in the high transpulmonary gradient group p<0.0001). Longer length of hospital stay was noted in high transpulmonary gradient group. References Naeije R, Vachiery JL, Yerly P, Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J. 2013 Jan;41(1):217-23. Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, Maurer G, Lang IM. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest. 2013 Mar;143(3):758-766. Gorlitzer M, Ankersmit J, Fiegl N, Meinhart J, Lanzenberger M, Unal K, Dunkler D, Kilo J, Wolner E, Grimm M, Grabenwoeger M. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation? Transpl Int. 2005 Apr;18(4):390-5. Erickson KW, Costanzo-No...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology Source Type: blogs